Main Quotes Calendar Forum
flag

FX.co ★ Stryker To Buy Inari Medical For About $4.9 Bln

back back next
typeContent_19130:::2025-01-06T21:45:00

Stryker To Buy Inari Medical For About $4.9 Bln

Stryker (SYK) has announced an agreement to acquire Inari Medical, Inc. (NARI) in a cash transaction valued at $4.9 billion, with an offer of $80 per share. This strategic purchase will enhance Stryker's presence in the burgeoning field of venous thromboembolism (VTE) by incorporating Inari's advanced peripheral vascular capabilities.

Kevin Lobo, the Chairman and CEO of Stryker, stated, "This acquisition broadens Stryker's ability to deliver critical interventions for patients suffering from peripheral vascular diseases. Inari's innovations are set to elevate care standards for VTE patients, strengthening Stryker's influence in endovascular treatments."

To execute the deal, Stryker will initiate a tender offer to acquire all outstanding shares of Inari's common stock at $80 apiece. The boards of directors for both companies have given unanimous approval to the transaction.

The acquisition is expected to finalize by the end of the first quarter of 2025, pending standard regulatory approvals and customary closing conditions.

Share this article:
back back next
loader...
all-was_read__icon
You have watched all the best publications
presently.
We are already looking for something interesting for you...
all-was_read__star
Recently published:
loader...
More recent publications...